Avidity Partners Management LP Takes $1.11 Million Position in Abivax SA Sponsored ADR $ABVX
Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology push
Sanofi Says Weak Decision-Making Hurt Pipeline, Promises More Disciplined R&D
Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks
uniQure (NASDAQ:QURE) Stock Rating Lowered by Wall Street Zen
Regeneron Q2 FY26 GAAP EPS falls 5% to $12.23; revenue rises 17% to $4.3 billion